Litcius/Paper detail

SARS-COV-2 spike protein fragment eases amyloidogenesis of α-synuclein

Andrew D. Chesney, Buddhadev Maiti, Ulrich H. E. Hansmann

2023The Journal of Chemical Physics13 citationsDOIOpen Access PDF

Abstract

Parkinson's disease is accompanied by the presence of amyloids in the brain that are formed of α-synuclein chains. The correlation between COVID-19 and the onset of Parkinson's disease led to the idea that amyloidogenic segments in SARS-COV-2 proteins can induce aggregation of α-synuclein. Using molecular dynamic simulations, we show that the fragment FKNIDGYFKI of the spike protein, which is unique for SARS-COV-2, preferentially shifts the ensemble of α-synuclein monomer toward rod-like fibril seeding conformations and, at the same time, differentially stabilizes this polymorph over the competing twister-like structure. Our results are compared with earlier work relying on a different protein fragment that is not specific for SARS-COV-2.

Topics & Concepts

Alpha-synucleinSpike (software development)Spike ProteinAmyloid (mycology)ChemistryMonomerBiophysicsProtein aggregationMolecular dynamicsSynucleinAmyloid fibrilProtein structureFragment (logic)FibrilCoronavirus disease 2019 (COVID-19)Parkinson's diseaseBiologyBiochemistryAmyloid βDiseaseMedicineComputer scienceComputational chemistryInorganic chemistrySoftware engineeringPathologyPolymerInfectious disease (medical specialty)Programming languageOrganic chemistryParkinson's Disease Mechanisms and TreatmentsAlzheimer's disease research and treatmentsAutophagy in Disease and Therapy